Lifevantage (LFVN) Expected to Post Quarterly Earnings on Tuesday

Lifevantage (NASDAQ:LFVN) is anticipated to announce its Q1 2027 results after the market closes on Tuesday, November 3rd. Analysts expect the company to announce earnings of $0.03 per share and revenue of $40.49 million for the quarter. Investors can find conference call details on the company’s upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Monday, November 9, 2026 at 4:30 PM ET.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Thursday, August 27th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $42.38 million for the quarter, compared to analysts’ expectations of $44.00 million. Lifevantage had a net margin of 2.78% and a return on equity of 21.56%. On average, analysts expect Lifevantage to post $0.39 EPS for the current fiscal year and $0.53 EPS for the next fiscal year.

Lifevantage Price Performance

Shares of LFVN stock opened at $5.76 on Tuesday. The business has a 50-day moving average of $6.24 and a 200 day moving average of $5.91. Lifevantage has a 1-year low of $3.90 and a 1-year high of $11.71. The stock has a market capitalization of $72.52 million, a PE ratio of 10.46 and a beta of 0.68.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date of this dividend was Tuesday, September 1st. Lifevantage’s dividend payout ratio is 50.00%.

Insider Activity at Lifevantage

In other news, insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $6.18, for a total transaction of $55,008.18. Following the sale, the insider owned 120,162 shares of the company’s stock, valued at approximately $742,601.16. The trade was a 6.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 13.58% of the company’s stock.

Wall Street Analyst Weigh In

LFVN has been the topic of several recent analyst reports. Zacks Research cut shares of Lifevantage from a “hold” rating to a “strong sell” rating in a report on Friday, October 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a report on Friday, August 21st. Finally, Lake Street Capital increased their price target on shares of Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research report on Friday, August 28th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $5.50.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care.

The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets.